Ipamorelin

Ipamorelin is a research-grade synthetic pentapeptide classified as a selective growth hormone secretagogue, designed for experimental studies on pulsatile GH release, body composition, and recovery in endocrine and performance models. By acting as a ghrelin (GHSR-1a) receptor agonist, it stimulates endogenous GH secretion with minimal impact on ACTH and cortisol compared with earlier secretagogues such as GHRP-6 and GHRP-2.

Growth Hormone And Metabolic Effects

• Induces dose-dependent GH release in animal and human studies, with potency similar to GHRP-6 but a notably selective profile that does not significantly alter prolactin, FSH, LH, or TSH levels in tested models.

• Used to investigate improvements in lean mass, fat loss, lipid markers, and insulin sensitivity, making it a tool of interest in hypogonadism, sarcopenia, and metabolic health research.

Recovery, Performance, And Repair

• Experimental and clinical-style reports associate ipamorelin-driven GH pulses with enhanced protein synthesis, muscle recovery, and connective-tissue support, including tendons and ligaments.

• Studies and practice-based evidence also explore benefits for sleep quality, energy, and general well-being parameters within broader anti-aging and performance-optimization paradigms.

For research purposes only. Not intended for human consumption or therapeutic use.